Harnessing the evolving CRISPR/Cas9 for precision oncology.

MLA

Li, Tianye, et al. “Harnessing the Evolving CRISPR/Cas9 for Precision Oncology.” Journal of Translational Medicine, vol. 22, no. 1, Aug. 2024, pp. 1–29. EBSCOhost, https://doi.org/10.1186/s12967-024-05570-4.

APA

Li, T., Li, S., Kang, Y., Zhou, J., & Yi, M. (2024). Harnessing the evolving CRISPR/Cas9 for precision oncology. Journal of Translational Medicine, 22(1), 1–29. https://doi.org/10.1186/s12967-024-05570-4

Chicago

Li, Tianye, Shuiquan Li, Yue Kang, Jianwei Zhou, and Ming Yi. 2024. “Harnessing the Evolving CRISPR/Cas9 for Precision Oncology.” Journal of Translational Medicine 22 (1): 1–29. doi:10.1186/s12967-024-05570-4.